学术探索
学术期刊
新闻热点
数据分析
智能评审

Molecular origins of cancer: Tumor angiogenesis

被引：1815
作者：
Kerbel, Robert S. [1 ,2 ]
机构：
[1] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2008年 / 358卷 / 19期
关键词：
D O I：
10.1056/NEJMra0706596
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2039 / 2049
页数：11
相关论文
共 106 条
[51]  
Karashima T, 2007, INT J ONCOL, V30, P937
[52]   Clinical translation of angiogenesis inhibitors [J].
Kerbel, R ;
Folkman, J .
NATURE REVIEWS CANCER, 2002, 2 (10) :727-739
[53]   Antiangiogenic therapy: A universal chemosensitization strategy for cancer? [J].
Kerbel, Robert S. .
SCIENCE, 2006, 312 (5777) :1171-1175
[54]   The anti-angiogenic basis of metronomic chemotherapy [J].
Kerbel, RS ;
Kamen, BA .
NATURE REVIEWS CANCER, 2004, 4 (06) :423-436
[55]   Vascular endothelial growth factor and its receptor as drug targets in hematological malignancies [J].
Kessler, Torsten ;
Fehrmann, Frauke ;
Bieker, Ralf ;
Berdel, Wolfgang E. ;
Mesters, Rolf M. .
CURRENT DRUG TARGETS, 2007, 8 (02) :257-268
[56]   Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity [J].
Klement, G ;
Baruchel, S ;
Rak, J ;
Man, S ;
Clark, K ;
Hicklin, DJ ;
Bohlen, P ;
Kerbel, RS .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (08) :R15-R24
[57]  
Klement G, 2006, J CLIN INVEST, V116, P3084, DOI 10.1172/JCI08829C1
[58]  
Klement G, 2006, J CLIN INVEST, V116, P2827, DOI 10.1172/JCI08829C1
[59]   Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer [J].
Kut, C. ;
Mac Gabhann, F. ;
Popel, A. S. .
BRITISH JOURNAL OF CANCER, 2007, 97 (07) :978-985
[60]   A CELL INITIATING HUMAN ACUTE MYELOID-LEUKEMIA AFTER TRANSPLANTATION INTO SCID MICE [J].
LAPIDOT, T ;
SIRARD, C ;
VORMOOR, J ;
MURDOCH, B ;
HOANG, T ;
CACERESCORTES, J ;
MINDEN, M ;
PATERSON, B ;
CALIGIURI, MA ;
DICK, JE .
NATURE, 1994, 367 (6464) :645-648
12345678910